4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-020349
Chief Executive Officer sold 26,000 shares at $7.40 ($192,400)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2018-03-16 | Sale | −26,000 | $7.40 | $192,400 | 1,968,789 | D: show line 1 in the form |
| Open-market sales · 26,000 sh · avg $7.40 · $192,400 | |||||||
Loading xslF345X03/doc4.xml…